Transscleral Diode Laser Cyclophotocoagulation for Uncontrolled Intraocular Pressure Secondary to Emulsification of Silicone Oil

Abstract

Pur po se: To evaluate the efficacy and safety of transscleral diode laser cyclophotocoagulation (TDCP) for treatment of uncontrolled intraocular pressure (IOP) elevation secondary to emulsification of silicone oil (SiO) injection. Ma te ri al and Met hod: In this retrospective case series, forty-one eyes of 41 patients who underwent TDCP for uncontrolled IOP secondary to emulsified SiO were reviewed. Main outcome measures included visual acuity (VA), IOP changes, number of antiglaucomatous medication, and postoperative complications. Re sults: Mean±SD follow-up was 30.2±10.3 months (range, 16-41 months). Mean preoperative BCVA was 20/666 and mean postoperative BCVA at final visit was 20/400 (p=0.02). Mean intraocular pressure (IOP) on the preoperative and last postoperative visit was 34.1±8.3 mmHg and 15.7±4.1 mmHg, respectively (p<0.001). The mean number of glaucoma medication was reduced from 3.1±0.6 at baseline to 1.1±1.2 at postoperative last visit (p<0.001). The postoperative complications were transient pain in 9 (21.9%) eyes and transient hypotony in 1 (2.4%) eye. Dis cus si on: TDCP is an effective and safe procedure for medically uncontrolled IOP secondary to emulsification of SiO. (Turk J Ophthalmol 2013; 43: 178-82

Keywords

• Diode laser
• refractory glaucoma
• silicone oil emulsification
• transscleral cyclophotocoagulation